BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chee CB, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis: LTBI diagnosis and treatment. Respirology 2013;18:205-16. [DOI: 10.1111/resp.12002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Peña-vázquez GI, Dominguez-fernández MT, Camacho-zamora BD, Hernandez-salazar M, Urías-orona V, De Peña M, de la Garza AL. In vitro simulated gastrointestinal digestion impacts bioaccessibility and bioactivity of Sweet orange (Citrus sinensis) phenolic compounds. Journal of Functional Foods 2022;88:104891. [DOI: 10.1016/j.jff.2021.104891] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Lauar ID, Faria LC, Romanelli RMC, Clemente WT. Latent tuberculosis: Risk factors, screening and treatment in liver transplantation recipients from an endemic area. World J Transplant 2021; 11(12): 512-522 [DOI: 10.5500/wjt.v11.i12.512] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
3 Dwenger LV, Funke N, Stephany P, Suarez I, Wiesmüller GA, Neuhann F. [Frequency Distribution and Risk Factors for Latent Tuberculosis in Contact Persons: Cologne 2012-2016]. Pneumologie 2021;75:567-76. [PMID: 33971674 DOI: 10.1055/a-1479-0168] [Reference Citation Analysis]
4 Khoufi EAA. Association between latent tuberculosis and ischemic heart disease: a hospital-based cross-sectional study from Saudi Arabia. Pan Afr Med J 2021;38:362. [PMID: 34367441 DOI: 10.11604/pamj.2021.38.362.28110] [Reference Citation Analysis]
5 Hunter OF, Kyesi F, Ahluwalia AK, Daffé ZN, Munseri P, von Reyn CF, Adams LV. Successful implementation of isoniazid preventive therapy at a pediatric HIV clinic in Tanzania. BMC Infect Dis 2020;20:738. [PMID: 33028260 DOI: 10.1186/s12879-020-05471-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
6 Hutchinson PE, Kee AR, Agrawal R, Yawata N, Tumulak MJ, Connolly JE, Chee S, Siak J. Singapore Ocular Tuberculosis Immunity Study (SPOTIS): Role of T-lymphocyte Profiling in Patients with Presumed Ocular Tuberculosis. Ocular Immunology and Inflammation. [DOI: 10.1080/09273948.2020.1767791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Deng M, Lv XD, Fang ZX, Xie XS, Chen WY. The blood transcriptional signature for active and latent tuberculosis. Infect Drug Resist 2019;12:321-8. [PMID: 30787624 DOI: 10.2147/IDR.S184640] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Klautau GB, da Mota NVF, Salles MJC, Burattini MN, Rodrigues DS. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study. BMC Infect Dis 2018;18:585. [PMID: 30453903 DOI: 10.1186/s12879-018-3508-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chee CBE, Reves R, Zhang Y, Belknap R. Latent tuberculosis infection: Opportunities and challenges. Respirology 2018;23:893-900. [PMID: 29901251 DOI: 10.1111/resp.13346] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 6.4] [Reference Citation Analysis]
10 Pan SW, Yen YF, Kou YR, Chuang PH, Su VY, Feng JY, Chan YJ, Su WJ. The Risk of TB in Patients With Type 2 Diabetes Initiating Metformin vs Sulfonylurea Treatment. Chest 2018;153:1347-57. [PMID: 29253553 DOI: 10.1016/j.chest.2017.11.040] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
11 Ruhwald M, de Thurah L, Kuchaka D, Zaher MR, Salman AM, Abdel-Ghaffar AR, Shoukry FA, Michelsen SW, Soborg B, Blauenfeldt T, Mpagama S, Hoff ST, Agger EM, Rosenkrands I, Aagard C, Kibiki G, El-Sheikh N, Andersen P. Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. Sci Rep 2017;7:45969. [PMID: 28387329 DOI: 10.1038/srep45969] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
12 Liu Y, Huang S, Jiang H, Xiong J, Wang Y, Ou M, Cai J, Yang C, Wang Z, Ge S, Xia N. The prevalence of latent tuberculosis infection in rural Jiangsu, China. Public Health 2017;146:39-45. [PMID: 28404472 DOI: 10.1016/j.puhe.2017.01.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
13 Rennert-May E, Hansen E, Zadeh T, Krinke V, Houston S, Cooper R. A Step toward Tuberculosis Elimination in a Low-Incidence Country: Successful Diagnosis and Treatment of Latent Tuberculosis Infection in a Refugee Clinic. Can Respir J 2016;2016:7980869. [PMID: 27445565 DOI: 10.1155/2016/7980869] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pan SW, Yen YF, Feng JY, Su VY, Kou YR, Su WJ. The Risk of Depressive Disorder Among Contacts of Tuberculosis Patients in a TB-endemic Area: A Population-based Cohort Study. Medicine (Baltimore) 2015;94:e1870. [PMID: 26512600 DOI: 10.1097/MD.0000000000001870] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
15 Pan SW, Kou YR, Hu TM, Wu YC, Lee YC, Feng JY, Su WJ. Assessment of latent tuberculosis infection in psychiatric inpatients: A survey after tuberculosis outbreaks. J Microbiol Immunol Infect 2016;49:575-83. [PMID: 26694909 DOI: 10.1016/j.jmii.2015.10.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
16 Olaru ID, Lange C, Sester M. Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis. Am J Respir Crit Care Med 2015;192:1021-2. [PMID: 26469848 DOI: 10.1164/rccm.201506-1192LE] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Blauenfeldt T, Wagner D, Aabye M, Heyckendorf J, Lange B, Lange C, Ernst M, Ravn P, Duarte R, Morais C, Hoffmann M, Schoch OD, Dominguez J, Latorre I, Ruhwald M. Thermostability of IFN-γ and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study. Tuberculosis (Edinb) 2016;98:7-12. [PMID: 27156612 DOI: 10.1016/j.tube.2015.04.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Machado-villarroel L, Acosta-loya JA, Orozco-andrade I, Bravo-rodríguez G, Dimakis-ramírez DA. Determinación del interferón-gamma en tuberculosis: Principios básicos y utilidad. NCT Neumología y Cirugía de Tórax 2015;74:197-206. [DOI: 10.35366/62385] [Reference Citation Analysis]
19 Costa ÁF, Lázari CS, Leite OHM. Tuberculose latente: rastreamento, métodos diagnósticos e tratamento. Rev Paul Reumatol 2014. [DOI: 10.46833/reumatologiasp.2014.13.4.11-16] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens J, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C. Risk Assessment of Tuberculosis in Immunocompromised Patients. A TBNET Study. Am J Respir Crit Care Med 2014;190:1168-76. [DOI: 10.1164/rccm.201405-0967oc] [Cited by in Crossref: 156] [Cited by in F6Publishing: 160] [Article Influence: 17.3] [Reference Citation Analysis]
21 Gutsfeld C, Olaru ID, Vollrath O, Lange C. Attitudes about tuberculosis prevention in the elimination phase: a survey among physicians in Germany. PLoS One 2014;9:e112681. [PMID: 25393241 DOI: 10.1371/journal.pone.0112681] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
22 Cakar B, Demir N, Karnak D, Ozkara S. Tuberculosis preventive treatment in a single medical center and evaluation of the results. Exp Ther Med 2014;8:1874-8. [PMID: 25371747 DOI: 10.3892/etm.2014.1988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
23 van Dissel JT, Joosten SA, Hoff ST, Soonawala D, Prins C, Hokey DA, O'Dee DM, Graves A, Thierry-Carstensen B, Andreasen LV, Ruhwald M, de Visser AW, Agger EM, Ottenhoff TH, Kromann I, Andersen P. A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine 2014;32:7098-107. [PMID: 25454872 DOI: 10.1016/j.vaccine.2014.10.036] [Cited by in Crossref: 162] [Cited by in F6Publishing: 165] [Article Influence: 18.0] [Reference Citation Analysis]
24 Blauenfeldt T, Heyckendorf J, Graff Jensen S, Lange C, Drabe C, Hermansen TS, de Thurah L, Lillebaek T, Eugen-Olsen J, Seersholm N, Hoff S, Bonde J, Ruhwald M. Development of a one-step probe based molecular assay for rapid immunodiagnosis of infection with M. tuberculosis using dried blood spots. PLoS One 2014;9:e105628. [PMID: 25184553 DOI: 10.1371/journal.pone.0105628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
25 O'Shea MK, Fletcher TE, Beeching NJ, Dedicoat M, Spence D, McShane H, Cunningham AF, Wilson D. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants. PLoS One 2014;9:e97366. [PMID: 24816576 DOI: 10.1371/journal.pone.0097366] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
26 Anibarro L, Pena A. Tuberculosis in patients with haematological malignancies. Mediterr J Hematol Infect Dis 2014;6:e2014026. [PMID: 24803999 DOI: 10.4084/MJHID.2014.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
27 Paritala H, Carroll KS. New targets and inhibitors of mycobacterial sulfur metabolism. Infect Disord Drug Targets 2013;13:85-115. [PMID: 23808874 DOI: 10.2174/18715265113139990022] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
28 Leung CC, Porcel JM, Takahashi K, Restrepo MI, Lee P, Wainwright C. Year in review 2013: Lung cancer, respiratory infections, tuberculosis, cystic fibrosis, pleural diseases, bronchoscopic intervention and imaging. Respirology 2014;19:448-60. [PMID: 24708034 DOI: 10.1111/resp.12250] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
29 Sultan B, Benn P, Mahungu T, Young M, Mercey D, Morris-Jones S, Miller RF. Comparison of two interferon-gamma release assays (QuantiFERON-TB Gold In-Tube and T-SPOT.TB) in testing for latent tuberculosis infection among HIV-infected adults. Int J STD AIDS 2013;24:775-9. [PMID: 23970606 DOI: 10.1177/0956462413486459] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]